Results 331 to 340 of about 59,693 (345)

Spironolactone and warfarin interaction

Clinical Pharmacology and Therapeutics, 1980
Spironolactone has been reported to diminish the hypoprothrombinemic effect of oral anticoagulants in animals and digitoxin blood levels in man by induction of hepatic enzymes. To evaluate this in man, single oral doses of racemic warfarin, 1.5 mg/kg body weight, with and without 200 mg oral spironolactine daily, were administered to 9 normal subjects.
Robert A O'Reilly, Robert A O'Reilly
openaire   +2 more sources

Spironolactone in the Treatment of Hirsutism

Acta Obstetricia et Gynecologica Scandinavica, 1986
Spironolactone (100 mg) for 25 days in each menstrual cycle was assessed over 6 months for treatment of hirsutism in 35 patients. Five patients withdrew due to either nausea or polymenorrhea. the latter problem was encountered in 16 patients. of the 30 remaining patients, 17 had a significant reduction in hair growth as assessed by Ferriman and Gallwey
M. Dowsett, M. Katz, C. J. Dewhurst, Michael Chapman, S. L. Jeffcoate, W. Hague   +5 more
openaire   +3 more sources

Spironolactone

American Heart Journal, 1978
H R, Ochs, D J, Greenblatt, G, Bodem, T W, Smith   +3 more
openaire   +2 more sources

SPIRONOLACTONE AND GYNÆCOMASTIA [PDF]

The Lancet, 1962
T.Albert Farmer, RonaldA. Restifo
  +6 more sources

Spironolactone Therapy and Gynecomastia

JAMA: The Journal of the American Medical Association, 1965
SINCE THE clinical introduction of spironolactone in 1957, there have been several reports of gynecomastia in men receiving this diuretic. These have appeared either as individual case reports or as an incidental single observation in a group of patients undergoing metabolic studies during treatment with spironolactone.
openaire   +3 more sources

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

, 2000
B. Pitt, F. Zannad, W. Remme, R. Cody, A. Castaigne, Alfonso T. Perez, J. Palensky, J. Wittes   +7 more
semanticscholar   +1 more source

Spironolactone and agranulocytosis

Australian and New Zealand Journal of Medicine, 2000
Hui Ch, Das Pk, Horvath N
openaire   +2 more sources

Spironolactone

2002
Badraddin M.H. Al-Hadiya, Fathalla Belal, Yousif A. Asiri, Othman A. Gubara   +3 more
openaire   +1 more source

HYPERKALAEMIA AND SPIRONOLACTONE

The Lancet, 1987
A.R. Morton, S.A. Crook
openaire   +2 more sources

Spironolactone in dermatology

Journal of the American Academy of Dermatology, 1992
S. Macdonald Hull, W.J. Cunliffe
openaire   +2 more sources